STERIS Q1 revenue $1.28B (+11% YoY), adj. EPS $2.00, GAAP EPS $1.25

STERIS plc

2024-Q1 EPS reported $1.25 revenue$1,284,542,000

Revenue of $1.28B, up 11% as reported and constant currency organic.
As reported diluted EPS $1.25; adjusted diluted EPS $2.00.
Fiscal 2024 outlook updated to reflect acquisition of BD surgical instrumentation assets (no financial details provided).
Constant currency organic revenue growth drove the quarter, with all segments contributing.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

STERIS plc reported fiscal 2024 first quarter ended June 30, 2023 results: revenue $1.28 billion, EPS $1.25; adjusted earnings increased to $2.00.

Period: fiscal 2024 first quarter ended June 30, 2023
Revenue: $1.28 billion
EPS: $1.25; adjusted earnings increased to $2.00
Result: reported results

Exact text from the filing

STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 first quarter ended June 30, 2023. Revenue as reported for the quarter increased 11% to $1.28 billion compared with $1.16 billion in the first quarter of fiscal 2023. Constant currency organic revenue (see

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

STERIS plc filing history →

Source: SEC EDGAR

accession 0001757898-23-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.